Envista Holdings (NVST) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Envista Holdings · Health Care · ref. ETF XLV · 52 calls · price $27.44
What the company does: Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally.
📈 Envista Holdings (NVST) stock price
$27.44+29.1% over range
Aug 28, 25low $18.95 · high $30.26Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
38% recommend buying · 8 analysts
📊 JPI status : Envista Holdings has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 NVST price target & analyst consensus — price $27.44
The price target · all analysts combined (8 targets)
Highest target · 1 firm of 8$33+20.3%
Median target · of 8 targets$29+5.7%
Lowest target · 1 firm of 8$21-23.5%
Current price$27.44
Where these 8 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
675%
$28 ↔ $33
Below
225%
$21 ↔ $27
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 8 ratings (last 6 months)
Strong Buy00%
Buy338%
Hold563%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 NVST price target all
All 52 calls, one by one, with our verdict on each firm.
→ See all 52 targets, analyst by analyst💡 The best analysts on NVST most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in NVST? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Envista Holdings? The JPI assistant answers using our backtest data.
📈 Envista Holdings fundamentals: valuation, margins & growth › open the full page
P/E 48.1Net margin 3.3 %Revenue growth +7.1 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 9 %
2023
Rev −0%Profit −141%
2024
Rev −2%
2025
Rev +8%
🔎 Detailed analyses
✅ Historical analyst reliability on NVST
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Evercore ISI Group ↗ | 100% | +19.3% | 4 |
| Credit Suisse | 75% | +15.1% | 4 |
| Baird ↗ | 67% | +67.0% | 3 |
| B of A Securities ↗ | 50% | +5.8% | 4 |
| Stifel ↗ | 50% | +5.5% | 6 |
| Mizuho ↗ | 50% | -15.8% | 2 |
| JP Morgan ↗ | 40% | +60.5% | 5 |
| Goldman Sachs ↗ | 25% | -3.5% | 4 |
| Morgan Stanley ↗ | 0% | -19.5% | 9 |
| Piper Sandler ↗ | 0% | -26.8% | 4 |
📊 What $1,000 invested in Envista Holdings would be worth › open the full page
In short — $1,000 invested in Envista Holdings 10 years ago would be worth $916 today, i.e. -1%/yr on average. Best year: 2021 (+34%), worst: 2023 (-29%). Price performance, excluding dividends.
If I'd invested $1,000 in Envista Holdings
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,385 | +38% |
| 3 years ago | $783 | -22% |
| 5 years ago | $781 | -22% |
Return by year (Envista Holdings)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +21% | $1,215 (+21%) |
| 2025 | +14% | $1,385 (+38%) |
| 2024 | -21% | $1,095 (+10%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Envista Holdings
Loading news…
📋 All analyst calls on NVST
Filtered on — · ✕ show all
Piper Sandler ↗
Aug 6, 26
■ Neutral neutral · not a buy · 🎯$28
Price at call : $28.15 — gap to target -1%
Today : $27.44 — gap to target +2%
🎯 on NVST : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
Piper Sandler ↗
Jul 29, 26
■ Neutral neutral · not a buy · 🎯$26
Price at call : $27.78 — gap to target -6%
Today : $27.44 — gap to target -5%
🎯 on NVST : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
BMO Capital ↗
Jul 9, 26
■ Market Perform neutral · not a buy · 🎯$27
Price at call : $25.91 — gap to target +4%
Today : $27.44 — gap to target -2%
🎯 on NVST : no call matured yet · 📊 on Health : 45.7% · +6.4% (35 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
▲ Overweight · 🎯$32
Price at call : $24.6 — upside +30%
Today : $27.44 — upside +17%
🎯 on NVST : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
■ Neutral neutral · not a buy · 🎯$29
Price at call : $24.24 — gap to target +20%
Today : $27.44 — gap to target +6%
🎯 on NVST : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Evercore ISI Group ↗
May 7, 26
▲ Outperform · 🎯$33
Price at call : $24.24 — upside +36%
Today : $27.44 — upside +20%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
▲ Outperform · 🎯$31
Price at call : $24.29 — upside +28%
Today : $27.44 — upside +13%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : May 7, 27
matures : May 7, 27
Morgan Stanley ↗
Apr 24, 26
■ Equal-Weight neutral · not a buy · 🎯$21
Price at call : $26.8 — gap to target -22%
Today : $27.44 — gap to target -23%
🎯 on NVST : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
See the other 44 calls, newest to oldest
■ Neutral neutral · not a buy · 🎯$29
Price at call : $26.94 — gap to target +8%
Today : $27.44 — gap to target +6%
🎯 on NVST : no call matured yet · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
Evercore ISI Group ↗
Apr 8, 26
▲ Outperform · 🎯$30
Price at call : $26.67 — upside +12%
Today : $27.44 — upside +9%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 35.9% · -8.7% (39 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
▲ Overweight · 🎯$34
Price at call : $30.26 — upside +12%
Today : $27.44 — upside +24%
🎯 on NVST : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
■ Neutral neutral · not a buy · 🎯$27
Price at call : $30.17 — gap to target -11%
Today : $27.44 — gap to target -2%
🎯 on NVST : 50% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
■ Neutral neutral · not a buy · 🎯$26
Price at call : $29.36 — gap to target -11%
Today : $27.44 — gap to target -5%
🎯 on NVST : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$31
Price at call : $29.36 — upside +6%
Today : $27.44 — upside +13%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48% · +12.4% (98 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Wells Fargo ↗
Feb 6, 26
■ Equal-Weight neutral · not a buy · 🎯$26
Price at call : $29.36 — gap to target -11%
Today : $27.44 — gap to target -5%
🎯 on NVST : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Piper Sandler ↗
Feb 6, 26
■ Neutral neutral · not a buy · 🎯$25
Price at call : $29.36 — gap to target -15%
Today : $27.44 — gap to target -9%
🎯 on NVST : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$27
Price at call : $23.66 — upside +14%
Today : $27.44 — upside -2%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48% · +12.4% (98 calls)
in progress (365j)
matures : Feb 4, 27
matures : Feb 4, 27
■ Neutral neutral · not a buy · 🎯$25
Price at call : $22.91 — gap to target +9%
Today : $27.44 — gap to target -9%
🎯 on NVST : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Feb 3, 27
matures : Feb 3, 27
Piper Sandler ↗
Jan 30, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $23.26 — gap to target -10%
Today : $27.44 — gap to target -23%
🎯 on NVST : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
■ Neutral neutral · not a buy · 🎯$24
Price at call : $24.34 — gap to target -1%
Today : $27.44 — gap to target -13%
🎯 on NVST : 50% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
■ Neutral neutral · not a buy · 🎯$22
Price at call : $21.85 — gap to target +1%
Today : $27.44 — gap to target -20%
🎯 on NVST : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Dec 16, 26
matures : Dec 16, 26
▲ Overweight · 🎯$24
Price at call : $22.1 — upside +9%
Today : $27.44 — upside -13%
🎯 on NVST : no call matured yet · 📊 on Health : 47.9% · +1.6% (194 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
▼ Underperform · 🎯$18
Price at call : $20.48 — upside -12%
Today : $27.44 — upside -34%
Expected -12% · Actual +34% · Reason (≤ −15%) : ✗ No
🎯 on NVST : 50% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
-33.6%
stock +34% · XLV +22%
matured Aug 1, 26
▲ Buy · 🎯$25
Price at call : $20.48 — upside +22%
Today : $27.44 — upside -9%
Expected +22% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48% · +12.4% (98 calls)
+33.6%
stock +34% · XLV +22%
matured Aug 1, 26
Morgan Stanley ↗
Aug 1, 25
■ Equal-Weight neutral · not a buy · 🎯$17
Price at call : $20.48 — gap to target -17%
Today : $27.44 — gap to target -38%
🎯 on NVST : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Aug 1, 26
matures : Aug 1, 26
Wells Fargo ↗
Aug 1, 25
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $20.48 — gap to target -7%
Today : $27.44 — gap to target -31%
🎯 on NVST : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Aug 1, 26
matures : Aug 1, 26
Piper Sandler ↗
Aug 1, 25
■ Neutral neutral · not a buy · 🎯$19
Price at call : $20.83 — gap to target -9%
Today : $27.44 — gap to target -31%
🎯 on NVST : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Aug 1, 26
matures : Aug 1, 26
■ Neutral neutral · not a buy · 🎯$22
Price at call : $19.96 — gap to target +10%
Today : $27.44 — gap to target -20%
🎯 on NVST : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Jul 29, 26
matures : Jul 29, 26
Evercore ISI Group ↗
Jul 9, 25
▲ Outperform · 🎯$23
Price at call : $20.38 — upside +13%
Today : $27.44 — upside -16%
Expected +13% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 35.9% · -8.7% (39 calls)
+26.4%
stock +26% · XLV +20%
matured Jul 9, 26
▲ Outperform · 🎯$23
Price at call : $18.53 — upside +24%
Today : $27.44 — upside -16%
Expected +24% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48.7% · +1.8% (76 calls)
+27.7%
stock +28% · XLV +15%
matured May 27, 26
■ Neutral neutral · not a buy · 🎯$18
Price at call : $16.39 — gap to target +10%
Today : $27.44 — gap to target -34%
🎯 on NVST : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : May 5, 26
matures : May 5, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $16.99 — gap to target +24%
Today : $27.44 — gap to target -23%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : May 2, 26
matures : May 2, 26
Piper Sandler ↗
Apr 30, 25
■ Neutral neutral · not a buy · 🎯$17
Price at call : $16.34 — gap to target +4%
Today : $27.44 — gap to target -38%
🎯 on NVST : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Apr 30, 26
matures : Apr 30, 26
B of A Securities ↗
Apr 29, 25
▲ Buy · 🎯$23
Price at call : $16.08 — upside +43%
Today : $27.44 — upside -16%
Expected +43% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 64.8% · +20.2% (105 calls)
+61.3%
stock +61% · XLV +4%
matured Apr 29, 26
■ Neutral neutral · not a buy · 🎯$21
Price at call : $17.13 — gap to target +23%
Today : $27.44 — gap to target -23%
🎯 on NVST : no call matured yet · 📊 on Health : 49.6% · +18.1% (119 calls)
in progress (365j)
matures : Mar 10, 26
matures : Mar 10, 26
■ Neutral neutral · not a buy · 🎯$19
Price at call : $18.43 — gap to target +3%
Today : $27.44 — gap to target -31%
🎯 on NVST : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Mar 6, 26
matures : Mar 6, 26
Morgan Stanley ↗
Mar 6, 25
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $17.83 — gap to target +7%
Today : $27.44 — gap to target -31%
🎯 on NVST : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Mar 6, 26
matures : Mar 6, 26
■ Hold neutral · not a buy
🎯 on NVST : no call matured yet · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Mar 6, 26
matures : Mar 6, 26
■ Hold neutral · not a buy
🎯 on NVST : no call matured yet · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Feb 25, 26
matures : Feb 25, 26
Wells Fargo ↗
Feb 6, 25
■ Equal-Weight neutral · not a buy · 🎯$21
Price at call : $21.25 — gap to target -1%
Today : $27.44 — gap to target -23%
🎯 on NVST : no call matured yet · 📊 on Health : 47% · +4.6% (149 calls)
in progress (365j)
matures : Feb 6, 26
matures : Feb 6, 26
■ Neutral neutral · not a buy · 🎯$23
Price at call : $21.79 — gap to target +6%
Today : $27.44 — gap to target -16%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : Feb 6, 26
matures : Feb 6, 26
Morgan Stanley ↗
Feb 6, 25
■ Equal-Weight neutral · not a buy · 🎯$20
Price at call : $21.79 — gap to target -8%
Today : $27.44 — gap to target -27%
🎯 on NVST : no call matured yet · 📊 on Health : 41.3% · -1.5% (196 calls)
in progress (365j)
matures : Feb 6, 26
matures : Feb 6, 26
■ Hold neutral · not a buy
🎯 on NVST : no call matured yet · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Feb 6, 26
matures : Feb 6, 26
Piper Sandler ↗
Feb 3, 25
■ Neutral neutral · not a buy · 🎯$18
Price at call : $20.13 — gap to target -11%
Today : $27.44 — gap to target -34%
🎯 on NVST : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Feb 3, 26
matures : Feb 3, 26
■ Hold neutral · not a buy · 🎯$22
Price at call : $21.45 — gap to target +3%
Today : $27.44 — gap to target -20%
🎯 on NVST : no call matured yet · 📊 on Health : 49.1% · +10.3% (112 calls)
in progress (365j)
matures : Jan 23, 26
matures : Jan 23, 26
▼ Underperform · 🎯$20
Price at call : $20.57 — upside -3%
Today : $27.44 — upside -27%
Expected -3% · Actual -2% · Reason (≤ −15%) : ✗ No
🎯 on NVST : 50% (2 calls matureds) · 📊 on Health : 57.1% · +12.3% (70 calls)
+2.1%
stock -2% · XLV +5%
matured Dec 4, 25
Piper Sandler ↗
Oct 31, 24
■ Neutral neutral · not a buy · 🎯$17
Price at call : $20.94 — gap to target -19%
Today : $27.44 — gap to target -38%
🎯 on NVST : no call matured yet · 📊 on Health : 42.5% · +4.1% (120 calls)
in progress (365j)
matures : Oct 31, 25
matures : Oct 31, 25
■ Hold neutral · not a buy
🎯 on NVST : no call matured yet · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Oct 31, 25
matures : Oct 31, 25
■ Neutral neutral · not a buy · 🎯$22
Price at call : $20.97 — gap to target +5%
Today : $27.44 — gap to target -20%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : Oct 31, 25
matures : Oct 31, 25
Leerink Partners ↗
Oct 31, 24
■ Market Perform neutral · not a buy · 🎯$23
Price at call : $20.97 — gap to target +10%
Today : $27.44 — gap to target -16%
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
in progress (365j)
matures : Oct 31, 25
matures : Oct 31, 25
Leerink Partners ↗
Feb 26, 24
▼ Underperform · 🎯$19
Price at call : $21.92 — upside -13%
Today : $27.44 — upside -31%
Expected -13% · Actual -6% · Reason (≤ −15%) : ✗ No
🎯 on NVST : 100% (1 call matured) · 📊 on Health : 54.5% · +10.0% (11 calls)
+5.8%
stock -6% · XLV +1%
matured Feb 25, 25
William Blair ↗
Feb 8, 24
■ Market Perform neutral · not a buy
🎯 on NVST : no call matured yet · 📊 on Health : 50% · +37.8% (20 calls)
in progress (365j)
matures : Feb 7, 25
matures : Feb 7, 25
Frequently asked questions
Should I buy Envista Holdings stock?
This isn't buy advice. For Envista Holdings, the analyst consensus is "Hold", with an average price target of $29.00 (+6% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (4 calls tracked on Envista Holdings). We show the numbers — you decide.
Is it too late to buy Envista Holdings? How high can it go?
The most bullish analyst target on Envista Holdings is $33.00 (+20% above today's price); the average is $29.00. That's the upside they see. Check how reliable those analysts have actually been on Envista Holdings on our site before trusting it.
Is Envista Holdings still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 10 analysts have a real record on Envista Holdings, the best hitting 100% over 4 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Envista Holdings? The case for and against
The arguments for and against, one by one, from the numbers: why invest in NVST (and why hesitate).
What has Envista Holdings's past performance been?
Historical returns and a "how much if I had invested" calculator: NVST performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX